Provided by Tiger Fintech (Singapore) Pte. Ltd.

Supernus Pharmaceuticals

32.34
-1.2500-3.72%
Post-market: 32.340.00000.00%16:34 EDT
Volume:690.52K
Turnover:22.58M
Market Cap:1.81B
PE:29.22
High:33.83
Open:33.83
Low:32.20
Close:33.59
Loading ...

Supernus:Got Paragraph Iv Notice Letters Notifying Third Parties Submitted Andas for Viloxazine Extended-Release Capsules EQ 100, 150, 200 Mg Base

THOMSON REUTERS
·
29 May

Supernus Announces Paragraph Iv Anda Filings for Qelbree

THOMSON REUTERS
·
29 May

Supernus Pharmaceuticals Announces Receipt of Paragraph IV ANDA Filings for Qelbree, Plans to Defend Patents

Reuters
·
29 May

Supernus Pharmaceuticals Inc. to Participate in Jefferies Global Healthcare Conference

Reuters
·
29 May

Optimistic Growth Prospects for Supernus Pharmaceuticals Driven by Qelbree’s Market Potential

TIPRANKS
·
07 May

Earnings Flash (SUPN) Supernus Pharmaceuticals Q1 Loss Per Share $0.21 Vs. FactSet Est. Loss $0.01

MT Newswires Live
·
07 May

Supernus Pharmaceuticals Q1 2025 GAAP EPS $(0.21), Sales $149.824M Beat $146.936M Estimate

Benzinga
·
07 May

Earnings Flash (SUPN) Supernus Pharma Q1 Revenue $149.8 Million Vs. FactSet Est. $147.9 Million

MT Newswires Live
·
07 May

BRIEF-Supernus Pharmaceuticals Q1 Adjusted Operating Earnings USD 25.9 Million Vs. IBES Estimate USD 24.1 Million

Reuters
·
07 May

Supernus Announces First Quarter 2025 Financial Results

THOMSON REUTERS
·
07 May

Supernus Pharmaceuticals Outlook FY Revenue USD 600-630 Million

THOMSON REUTERS
·
07 May

Supernus Pharmaceuticals Earnings: What To Look For From SUPN

StockStory
·
05 May

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

StockStory
·
29 Apr

What Makes Supernus (SUPN) a New Buy Stock

Zacks
·
29 Apr

3 Healthcare Stocks with Mounting Challenges

StockStory
·
24 Apr

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

StockStory
·
10 Apr

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

StockStory
·
08 Apr

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

StockStory
·
02 Apr

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

StockStory
·
21 Mar

Down -20.07% in 4 Weeks, Here's Why Supernus (SUPN) Looks Ripe for a Turnaround

Zacks
·
17 Mar